Mes-Masson AM - Search Results

1

Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes.

Birch AH, Quinn MC, Filali-Mouhim A, Provencher DM, Mes-Masson AM, Tonin PN. Birch AH, et al. Mol Carcinog. 2008 Jan;47(1):56-65. doi: 10.1002/mc.20361. Mol Carcinog. 2008. PMID: 17620309

2

Testicular adenoma and seminal vesicle engorgement in polyomavirus large-T antigen transgenic mice.

Chalifour LE, Mes-Masson AM, Gomes ML, Wang NS. Chalifour LE, et al. Mol Carcinog. 1992;5(3):178-89. doi: 10.1002/mc.2940050304. Mol Carcinog. 1992. PMID: 1375029

3

Primary cultures of normal and tumoral human ovarian epithelium: a powerful tool for basic molecular studies.

Lounis H, Provencher D, Godbout C, Fink D, Milot MJ, Mes-Masson AM. Lounis H, et al. Exp Cell Res. 1994 Dec;215(2):303-9. doi: 10.1006/excr.1994.1346. Exp Cell Res. 1994. PMID: 7526992

4

Absence of human papillomavirus sequences in ovarian pathologies.

Trottier AM, Provencher D, Mes-Masson AM, Vauclair R, Coutlée F. Trottier AM, et al. J Clin Microbiol. 1995 Apr;33(4):1011-3. doi: 10.1128/jcm.33.4.1011-1013.1995. J Clin Microbiol. 1995. PMID: 7790425 Free PMC article.

5

Discordance in p53 mutations when comparing ascites and solid tumors from patients with serous ovarian cancer.

Provencher DM, Lounis H, Fink D, Drouin P, Mes-Masson AM. Provencher DM, et al. Tumour Biol. 1997;18(3):167-74. doi: 10.1159/000218027. Tumour Biol. 1997. PMID: 9143413

6

Analysis of the p16 tumor suppressor gene in early-stage prostate cancer.

Gu K, Mes-Masson AM, Gauthier J, Saad F. Gu K, et al. Mol Carcinog. 1998 Mar;21(3):164-70. Mol Carcinog. 1998. PMID: 9537647

7

Risk factors for familial and sporadic ovarian cancer among French Canadians: a case-control study.

Godard B, Foulkes WD, Provencher D, Brunet JS, Tonin PN, Mes-Masson AM, Narod SA, Ghadirian P. Godard B, et al. Am J Obstet Gynecol. 1998 Aug;179(2):403-10. doi: 10.1016/s0002-9378(98)70372-2. Am J Obstet Gynecol. 1998. PMID: 9731846

8

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.

Tonin PN, Mes-Masson AM, Futreal PA, Morgan K, Mahon M, Foulkes WD, Cole DE, Provencher D, Ghadirian P, Narod SA. Tonin PN, et al. Am J Hum Genet. 1998 Nov;63(5):1341-51. doi: 10.1086/302099. Am J Hum Genet. 1998. PMID: 9792861 Free PMC article.

9

Mapping of chromosome 3p deletions in human epithelial ovarian tumors.

Lounis H, Mes-Masson AM, Dion F, Bradley WE, Seymour RJ, Provencher D, Tonin PN. Lounis H, et al. Oncogene. 1998 Nov 5;17(18):2359-65. doi: 10.1038/sj.onc.1202152. Oncogene. 1998. PMID: 9811467

10

Expression of FHIT in primary cultures of human epithelial ovarian tumors and malignant ovarian ascites.

Manning AP, Mes-Masson AM, Seymour RJ, Tetrault M, Provencher DM, Tonin PN. Manning AP, et al. Mol Carcinog. 1999 Mar;24(3):218-25. doi: 10.1002/(sici)1098-2744(199903)24:3<218::aid-mc8>3.0.co;2-a. Mol Carcinog. 1999. PMID: 10204806

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters